SPONSOR
University College, London
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 3, Phase 2, Phase 1, Phase 1, Phase 2, Phase 3
Conditions studied: DementiaWaldenstrom MacroglobulinemiaLarge B-cell LymphomaMultiple MyelomaBladder CancerLung Cancer, Non-small CellSmall Cell Lung CancerPleural MesotheliomaMusculoskeletal DisordersRenal Cell Carcinoma
University College, London is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Dementia, Waldenstrom Macroglobulinemia, Large B-cell Lymphoma, Multiple Myeloma.
The trial portfolio spans Phase 2, Phase 3, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University College, London
How many clinical trials has University College, London sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by University College, London, of which 10 are actively recruiting participants. These trials cover conditions including Dementia, Waldenstrom Macroglobulinemia, Large B-cell Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University College, London research focus on?
University College, London clinical trials span Dementia, Waldenstrom Macroglobulinemia, Large B-cell Lymphoma, Multiple Myeloma, Bladder Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University College, London clinical trial?
To participate in a University College, London trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University College, London trials with current recruitment status updated daily.
Clinical Trials by University College, London
NCT06241287
Recruiting
BELIDE: Better Living With Non-memory-led Dementia
Dementia
NCT04061512 Phase 2, Phase 3
Recruiting
Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia
Waldenstrom Macroglobulinemia
NCT06071871 Phase 2
Recruiting
A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma
Large B-cell Lymphoma
NCT04795882 Phase 1
Recruiting
A New Study Evaluating the Activity of Modular CAR T for mYeloma
Multiple Myeloma
NCT04106115 Phase 1, Phase 2
Recruiting
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
Bladder Cancer
NCT05628376
Recruiting
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
Lung Cancer, Non-small Cell
NCT07112508
Recruiting
PRISM: The PRimary Care Individual Social Norms MSK Data Dashboard: a Feasibility Trial
Musculoskeletal Disorders
NCT03288532 Phase 3
Recruiting
Renal Adjuvant MultiPle Arm Randomised Trial
Renal Cell Carcinoma
NCT06929871
Recruiting
Mako Cementless TKA vs Mako Cemented TKA
Total Knee Replacement
NCT05635162 Phase 2
Recruiting
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
Mantle Cell Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology